The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Industry 4.0! Agility! Productivity gain! Digitalization! Data Culture! Shortages! Waste! Innovation! Rapid Change! Risk Management! QbD! Cost Reduction! Key words behind initiatives that are, and will continue to be, on tactical, strategic and vision boards of injectables developers and manufacturers alike. The elements transcending daunting barriers raised when facing such endeavors are grounded in the Science and Knowledge defining the product and the process realization at specific manufacturing premises. A whole new level of insight is now accessible to parenteral processing when using SmartSkin technology. Unique in its kind, it’s rapid and easy to use technology that reveals the location and magnitude of in-process interactions between the product and the equipment handling it. SmartSkin technology, is tailored to product as a “smart replica drone” acquiring in real time, digital data that makes visible and quantifies interactions in real time.
Results and value gained from application of SmartSkin “audits” along fill/finish and packaging operations will be shared. Case studies relevant to vials, syringes cartridges etc, will illustrate applications and outcomes relevant across injectables development, clinical and commercial manufacturing. Audience will gain insights on how SmartSkin’s Operators “App” can be utilized to secure optimal line performance prior to initiating a manufacturing run.
Speaker(s):
Jeffrey
Cremi,
Associate Director, Engineering,
Merck & Co., Inc.
